NCT06271408View on ClinicalTrials.gov

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

PHASE1RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution

Aerosolized albuterol

DEVICE

Vibrating Mesh Nebulizer

A vibrating mesh nebulizer will be used to deliver aerosolized albuterol

DEVICE

Metered Dose Inhaler

A metered dose inhaler will be used to deliver aerosolized albuterol

DEVICE

Jet Nebulizer

A jet nebulizer will be used to deliver aerosolized albuterol

Trial Locations (1)

22947

RECRUITING

University of Virginia Sheridan Snyder Translational Fontaine Research Unit, Charlottesville

Sponsors

Lead Sponsor

Polarean, Inc.

Collaborators (1)

Aerogen
All Listed Sponsors
collaborator

Aerogen

INDUSTRY

lead

Polarean, Inc.

INDUSTRY